Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PESDA microbubbles
- Development stage
- Preclinical
- Lead developer
- University of Nebraska
- Modality
- Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
**PESDA microbubbles** are an investigational perfluorocarbon-gas ultrasound microbubble formulation made with sonicated dextrose albumin. Developed initially as an intravenous echocardiographic contrast agent, PESDA was also studied as an ultrasound-responsive carrier for localized vascular delivery of bound oligonucleotides, genes, and proteins. The albumin shell can bind antisense oligonucleotides, while low-frequency ultrasound can disrupt microbubbles and enhance local payload deposition or thrombolysis. Preclinical studies investigated anti-c-myc delivery to injured coronary and carotid arteries to reduce neointimal hyperplasia, ultrasound-enhanced declotting of thrombosed arteriovenous dialysis grafts, and VEGF delivery for myocardial angiogenesis. PESDA has no established marketed brand or single commercial sponsor. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16513520/))
- Other names
- perfluorocarbon-exposed sonicated dextrose albumin microbubblesPESDA
Beyond the preview
Go deeper on PESDA microbubbles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PESDA microbubbles.